Global Oncology Companion Diagnostic Market Size & Trends Report Segmented by Product & Services (Instrument, Consumables, Software), Technology (PCR, NGS, IHC, ISH), Cancer Type (Lung, Breast, Prostate), End-user & Regional Forecast to 2030

1. Introduction
   • Introduction
   • Market Scope
     • Market Definition
     • Segments Covered
     • Regional Segmentation
   • Research Timeframe
   • Currency Considered
   • Study Limitations
   • Stakeholders
   • List of Abbreviations
   • Key Conferences and Events (2025-2026)
2. Research Methodology
   • Secondary Research
   • Primary Research
   • Market Estimation
     • Bottom-Up Approach
     • Top-Down Approach
   • Market Forecasting
3. Executive Summary
   • Oncology Companion Diagnostic Marke"4">
   • Market Overview
     • Market Dynamics
       • Drivers
         • Rising prevalence of cancer worldwide
         • Increasing adoption of precision medicine in oncology
         • Growing demand for targeted cancer therapies
         • Advancements in molecular diagnostics, including NGS and liquid biopsy
         • Regulatory support for companion diagnostics in drug approvals
       • Restraints
         • High costs associated with developing and validating companion diagnostics
         • Stringent regulatory requirements delaying market entry
         • Limited reimbursement policies affecting test accessibility
       • Opportunities
         • Growing demand for minimally invasive and blood-based diagnostics
         • Development of multi-cancer early detection (MCED) technologies
         • Growth of comprehensive genomic profiling using NGS
         • Expansion in emerging markets with rising healthcare investments
       • Key Market Trendsng integration of AI and machine learning in diagnostic tools
       • Co-development of companion diagnostics with therapeutic product
       • Shift toward decentralized and point-of-care companion diagnostics
     • Unmet Market Needs
     • Industry Speaks
"5">
4. Global Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Product & Services, USD Million
   • Introduction
   • Product
     • Instrument
     • Consumables
     • Software
   • Services
5. Global Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Technology, USD Million
   • Introduction
   • Polymerase Chain Reaction (PCR)
   • Next-Generation Sequencing (NGS)
   • Immunohistochemistry (IHC)
   • In Situ Hybridization (ISH)
   • Others
6. Global Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Cancer Type, USD Million
   • Introduction
   • Lung Cancer
   • Breast Cancer
   • Leukaemia
   • Colorectal Cancer
   • Prostate Cancer
   • Oth>Global Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By End-user, USD Million
     • Introduction
     • Hospitals
     • Diagnostic Centers
     • Academic & Research Institutes
     • Others
   • Global Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Region, USD Million
     • Introduction
     • North America Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Country, USD Million
       • US
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Canada
         • Market Size & Forecast, Bast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
     • Europe Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Country, USD Million
       • UK
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Germany
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)e & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Italy
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Spain
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Rest of Europe
         • Market Size & Forecast, By Product & Services (USD MiD Million)
         • Market Size & Forecast, By End-user (USD Million)
     • Asia Pacific (APAC) Oncology Companion Diagnostic Market Size & Forecast (2023-2030), By Country, USD Million
       • China
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Japan
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • India
         • Market Size & Forecast, By Product & cast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
       • Rest of Asia Pacific
         • Market Size & Forecast, By Product & Services (USD Million)
         • Market Size & Forecast, By Technology (USD Million)
         • Market Size & Forecast, By Cancer Type (USD Million)
         • Market Size & Forecast, By End-user (USD Million)
     • Latin America (LATAM) Oncology Companion Diagnostic Market Size & Forecast (2023-2030), USD Million
       • Market Size & Forecast, By Product & Services (USD Million)
       • Market Size & Forecast, By Technology (USD Million)
       • Market Size & Forecast, By Cancer Type (USD Million)
       • Market Size & Forecast, By End-user (USD Million)
     • Middle East & Africa (MEA) Oncology Companion Diagnostic Markervices (USD Million)
     • Market Size & Forecast, By Technology (USD Million)
     • Market Size & Forecast, By Cancer Type (USD Million)
     • Market Size & Forecast, By End-user (USD Million)
   • Competitive Landscape
     • Key Players and their Competitive Positioning
       • Key Player Comparison
       • Segment-wise Player Mapping
       • Market Share Analysis (2024)
       • Company Categorization Matrix
         • Dominants/Leaders
         • New Entrants
         • Emerging Players
         • Innovative Players
       • Key Strategies Assessment, By Player (2022-2025)
         • New Product Launches
         • Partnerships, Agreements, & Collaborations
         • Mergers & Acquisitions
         • Geographic Expansion

11. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Agilent Technologies Inc.
• Illumina Inc.
• QIAGEN
• Thermo Fisher Scientific Inc.
• Foundation Medicine Inc.
• Myriad Genetics, Inc.
• Hoffmann-La Roche Ltd.
• BioMrieux
• Abbott
• Leica Biosystems
• Other Prominent Players

Note: *Indicative list

**For listed companies